.jpg)
- Jan 9, 2018
Aravax forms Scientific Advisory Board
9th January 2018, California, United States of America – Aravax, an Australian biotechnology company revolutionising peanut allergy...
- Nov 17, 2017
Aravax forms research collaboration with Stanford University
17th November 2017 – Aravax today signed a collaborative agreement with Stanford University in California. The Stanford research group,...
- May 16, 2017
Australian Biotech company launches clinical trials for revolutionary peanut allergy treatment
16 May 2017, Melbourne, Victoria – Australian biotechnology company Aravax has commenced clinical trials of a potentially life-changing...
- Jan 20, 2017
Aravax forms research collaboration with Benaroya Research Institute
20th January 2017, Melbourne, Victoria – Today Aravax established a collaboration with the prestigious Benaroya Research Institute in...
- Nov 23, 2015
$9 million cash injection for two victorian biotech companies
23 November 2015, Melbourne, Victoria – Two new Victorian medical technology companies have been awarded $9 million in venture capital...